Kelly, A S.(2007). Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. Vascular Medicine, 12(4), 311-318. doi:10.1177/1358863x07084200
Remember to check citations for accuracy before including them in your work.